Longterm Influence of Pediatric Long COVID Syndrome

Recruiting

• Conditions: COVID-19-Associated Encephalitis; Long COVID
• Interventions: Diagnostic Test: Brain MRI

• Registration Number: NCT05566392
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2022-10-02
• Study First Submitted QC: 2022-10-02
• Study First Posted: 2022-10-04
• Study Start: 2022-10-20
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-05
• Last Update Posted: 2024-08-06
• Primary Completion: 2025-10
• Study Completion: 2030-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Age 6-18 years old
• Has been diagnosed COVID-19 before

Read More

Exclusion Criteria

• History of neuropsychiatric disorders
• Have some device not allowed for MRI

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Coronavirus disease (COVID)	Brain MRI	Pediatric patients who was diagnosed as COVID
Healthy	Brain MRI	Pediatric participants who hadn't been diagnosed COVID before

Primary Outcome Measures

Name	Time	Method
Difference between COVID and healthy group	1 years after enrollment for primary evaluation	The neuroimage difference between COVID and healthy group and the correlation with neuropsychiatric evaluation

Trial Locations

Locations (1)

National Taiwan University Children Hospital Pediatric Neurology Department; 🇨🇳 Taipei, Taiwan